Printer Friendly

Articles from The Fly (June 19, 2020)

1-50 out of 50 article(s)
Title Author Type Words
Acasti Pharma receives FDA response to TRILOGY 1 briefing package. 170
Action Economics Survey results. 196
AMC reverses course, requires guests to wear masks at theatres. 376
AMC will not mandate guests wear masks in theaters, Variety reports. 154
Asian Market Update:. 204
BMW, Mercedes-Benz put automated driving alliance temporarily on hold. 222
Capstone Turbine announces long-term FPP service contract in Mexico. 160
Catalyst Biosciences presents preclinical FIX gene therapy data. 248
Cinedigm provides update on upcoming key OTT initiatives. 245
Cinedigm reports 13.2M monthly active ad-supported viewers in May. 245
CLIA members to extend suspension of cruise ops from U.S. ports until Sep 15. 277
CLIA members to voluntarily extend cruise ops from U.S. ports until September 15. 277
CymaBay presents data from Phase 2 study of seladelpar in PBC. Clinical report 259
Delta Apparel expands digital print business with Phoenix, Arizona facility. 213
Eli Lilly, Boehringer Ingelheim present full results from Emperial trials. 247
EnWave announces equity incentive grants. 292
EnWave installs 60kW REV processing line for The Green Organic Dutchman. 180
FDA approves new Depuxient pre-filled pen. 306
FDA approves new Dupixent pre-filled pen. 294
Fed to adjust bank stress tests, look at various COVID scenarios. 363
Fly Intel: Top five analyst downgrades. 229
Fly Intel: Top five analyst upgrades. 279
Four Corners Property Trust issues COVID-19 update. 650
FX Update: Narrow ranges have been prevailing. 336
FX Update: The dollar has been trading mostly narrow ranges. 300
Genentech says Phase III IPATential150 study met co-primary endpoint. 157
GSK announces FDA Advisory Committee meeting to review belantamab mafodotin. 174
Happiness Biotech provides update on COVID-19 testing kits. 181
Hyliion, Tortoise Acquisition announce merger, NYSE listing under symbol 'HYLN'. 288
Immuron enters partnership with CSIRO to produce a new oral therapeutic for DoD. 200
Janus Henderson Group intends to reopen Class D shares of mutual funds. 151
Lear rises after Halverson appointment to board spurs activist speculation. 184
Nasdaq pledges continued commitment to diversity, inclusion. 334
Nokia demonstrates live C-Band network in the U.S. 231
Nymox expects to file submissions for Fexapotide by end of Q3, early Q4. 257
On The Fly: ETF fund flow highlights. 158
Ovid Therapeutics receives Rare Pediatric Disease Designation for OV101. 186
PermRock Royalty Trust declares no monthly cash distributions for June. 284
Roche says FDA approves cobas EZH2 mutation test as companion diagnostic. 163
Sanofi announces long-term efficacy, safety data for fitusiran. 363
Sanofi granted approval for Dupixent in China. 188
Synalloy intends to cumulate votes for five nominees, responds to Privet, UPG. 490
Tesla workers hold Juneteenth rally at Fremont factory, Verge says. 215
The slight narrowing in the U.S. current account deficit. 244
The U.S. state level employment data. 186
Treasury Action: yields are dipping as risk appetite eases. 161
Treasury Market Outlook: a more positive tone in risk sees U.S. futures about 0.8% firmer. 181
U.S. equity futures are running higher. 195
uniQure treats first two patients in Phase I/II trial of AMT-130. Clinical report 194
Veru enrolls first patient in Phase 2 trial of VERU-111 for COVID-19. 153

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters